Li Y - Search Results

1

Intratumoral administration of STING-activating nanovaccine enhances T cell immunotherapy.

Jiang X, Wang J, Zheng X, Liu Z, Zhang X, Li Y, Wilhelm J, Cao J, Huang G, Zhang J, Sumer B, Lea J, Lu Z, Gao J, Luo M. Jiang X, et al. Among authors: li y. J Immunother Cancer. 2022 May;10(5):e003960. doi: 10.1136/jitc-2021-003960. J Immunother Cancer. 2022. PMID: 35623658 Free PMC article.

2

Nanoengineered targeting strategy for cancer immunotherapy.

Yin WM, Li YW, Gu YQ, Luo M. Yin WM, et al. Acta Pharmacol Sin. 2020 Jul;41(7):902-910. doi: 10.1038/s41401-020-0417-3. Epub 2020 May 12. Acta Pharmacol Sin. 2020. PMID: 32398683 Free PMC article. Review.

3

Epigenetic activation of the TUSC3 gene as a potential therapy for XMEN disease.

Ding H, Li Y, Fang M, Chen J, Liu L, Lu Z, Hou J, Luo M. Ding H, et al. Among authors: li y. J Allergy Clin Immunol. 2023 Jun;151(6):1622-1633.e10. doi: 10.1016/j.jaci.2023.04.003. Epub 2023 Apr 21. J Allergy Clin Immunol. 2023. PMID: 37086924

4

CD300ld on neutrophils is required for tumour-driven immune suppression.

Wang C, Zheng X, Zhang J, Jiang X, Wang J, Li Y, Li X, Shen G, Peng J, Zheng P, Gu Y, Chen J, Lin M, Deng C, Gao H, Lu Z, Zhao Y, Luo M. Wang C, et al. Among authors: li y, li x. Nature. 2023 Sep;621(7980):830-839. doi: 10.1038/s41586-023-06511-9. Epub 2023 Sep 6. Nature. 2023. PMID: 37674079

5

Targeting PMN-MDSCs via CD300ld receptor for cancer immunotherapy.

Li Y, Wang C, Lu Z, Luo M. Li Y, et al. Clin Transl Med. 2024 Jan;14(1):e1534. doi: 10.1002/ctm2.1534. Clin Transl Med. 2024. PMID: 38205725 Free PMC article. No abstract available.

6

Calcification-associated molecular traits and therapeutic strategies in hormone receptor-positive HER2-negative breast cancer.

Li Y, Xu Y, Lin C, Jin X, Ma D, Shao Z. Li Y, et al. Cancer Biol Med. 2024 Apr 9;21(5):400-15. doi: 10.20892/j.issn.2095-3941.2023.0492. Cancer Biol Med. 2024. PMID: 38605478 Free PMC article.

7

Molecular Characterization and Classification of HER2-Positive Breast Cancer Inform Tailored Therapeutic Strategies.

Li YW, Dai LJ, Wu XR, Zhao S, Xu YZ, Jin X, Xiao Y, Wang Y, Lin CJ, Zhou YF, Fu T, Yang WT, Li M, Lv H, Chen S, Grigoriadis A, Jiang YZ, Ma D, Shao ZM. Li YW, et al. Among authors: li m. Cancer Res. 2024 Nov 4;84(21):3669-3683. doi: 10.1158/0008-5472.CAN-23-4066. Cancer Res. 2024. PMID: 39186675

8

The predictive value of early oral motor assessments for neurodevelopmental outcomes of moderately and late preterm infants.

Zhang X, Zhou M, Yin H, Dai Y, Li Y. Zhang X, et al. Among authors: li y. Medicine (Baltimore). 2017 Dec;96(50):e9207. doi: 10.1097/MD.0000000000009207. Medicine (Baltimore). 2017. PMID: 29390342 Free PMC article.

9

Risk analysis of cardiovascular toxicity in patients with lymphoma treated with CD19 CAR T cells.

Liu Y, Yuan X, Yang X, Yang B, Liu G, Xu X, Wang S, He Z, Wang F, Li Y. Liu Y, et al. Among authors: li y. J Transl Med. 2025 Jan 4;23(1):8. doi: 10.1186/s12967-024-06035-4. J Transl Med. 2025. PMID: 39754193

10

Integrative multiomics reveals common endotypes across PSEN1, PSEN2, and APP mutations in familial Alzheimer's disease.

Valdes P, Caldwell AB, Liu Q, Fitzgerald MQ, Ramachandran S, Karch CM; Dominantly Inherited Alzheimer Network (DIAN); Galasko DR, Yuan SH, Wagner SL, Subramaniam S. Valdes P, et al. Alzheimers Res Ther. 2025 Jan 4;17(1):5. doi: 10.1186/s13195-024-01659-6. Alzheimers Res Ther. 2025. PMID: 39754192

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

238,916 results

Search Page

Filters